{
    "clinical_study": {
        "@rank": "8362", 
        "acronym": "CONDUCTOME", 
        "arm_group": {
            "arm_group_label": "CONDUCTOME", 
            "arm_group_type": "Experimental", 
            "description": "MEG and MRI"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the correlation between functional MEG analysis of\n      the tumor and its periphery and the tumor stage and treatment response."
        }, 
        "brief_title": "Glial Tumors Electromagnetic Signature Study by MagnetoEncephaloGraphy (MEG) \"CONDUCTOME\"", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Cerebral Primitive Tumor With Chirurgical Indication", 
        "condition_browse": {
            "mesh_term": "Glioma"
        }, 
        "detailed_description": {
            "textblock": "A better tumor grade definition would provide an optimized surgical care, prognosis and\n      therapeutical response evaluation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  more or equal than 18 years old\n\n          -  patient affiliated to social security or similarly regime\n\n          -  informed consent form signed\n\n          -  supra-tentorial primitive cerebral tumor\n\n        Exclusion Criteria:\n\n          -  Pregnant women and lactating mothers\n\n          -  Ward of court or under guardianship\n\n          -  Adult unable to express their consent\n\n          -  Person deprived of freedom by judicial or administrative decision\n\n          -  Person hospitalized without their consent\n\n          -  Person under legal protection\n\n          -  Magnetic Resonance Imaging (MRI) contraindication (implanted material non\n             MRI-compatible, ferro-magnetic foreign body, claustrophobia)\n\n          -  Patients needed emergency medical care for other pathology\n\n          -  severely altered general health (Performance Status 3 or 4)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02077504", 
            "org_study_id": "CONDUCTOME"
        }, 
        "intervention": {
            "arm_group_label": "CONDUCTOME", 
            "description": "CONDUCTOME", 
            "intervention_name": "MEG and MRI", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 28, 2014", 
        "location": {
            "contact": {
                "email": "francois.berger@cea.fr", 
                "last_name": "Fran\u00e7ois BERGER, MD, PhD"
            }, 
            "contact_backup": {
                "email": "csandreballester@chu-grenoble.fr", 
                "last_name": "Caroline SANDRE-BALLESTER, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Grenoble", 
                    "country": "France", 
                    "zip": "38000"
                }, 
                "name": "CLINATEC"
            }, 
            "investigator": [
                {
                    "last_name": "Fran\u00e7ois BERGER, Pr", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Alexandre KRAINIK, Pr", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Sylvie GRAND, Dr", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Dominique HOFFMANN, Dr", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Emmanuel GAY, Pr", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Caroline PASTERIS, Dr", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Julien PAVILLER, dr", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Magnetoencephalographic Study of Glial Tumors Electromagnetic Signature", 
        "overall_contact": {
            "email": "francois.berger@cea.fr", 
            "last_name": "Fran\u00e7ois BERGER, MD, PhD", 
            "phone": "+ 33 4 38 78 15 18"
        }, 
        "overall_contact_backup": {
            "email": "csandreballester@chu-grenoble.fr", 
            "last_name": "Caroline SANDRE-BALLESTER, PhD", 
            "phone": "+ 33 4 38 78 28 51"
        }, 
        "overall_official": {
            "affiliation": "University Grenoble Hospital", 
            "last_name": "Fran\u00e7ois BERGER, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Magnetoencephalography (MEG) and Magnetic Resonance Imaging (MRI) data in tumor grade prediction", 
                "safety_issue": "No", 
                "time_frame": "1 week before exeresis"
            }, 
            {
                "measure": "anatomopathologic and clinical data in tumor grade prediction", 
                "safety_issue": "No", 
                "time_frame": "1 week after exeresis"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02077504"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Measurement of molecules involved in glial cells neuralisation expression in tumor samples", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 month after surgery"
            }, 
            {
                "measure": "Tumoral growth modelisation from patient MEG and MRI data", 
                "safety_issue": "No", 
                "time_frame": "Up to 1 month after surgery"
            }
        ], 
        "source": "University Hospital, Grenoble", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Grenoble", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}